Study looks at effectiveness of pharmacist-delivered MAT to treat opioid use disorder

OPIOID STUDY: Susan Lim, site manager, and Joe Robillard, pharmacy technician, work on prescription orders at a Genoa Healthcare pharmacy inside a Gateway Healthcare clinic in Pawtucket. Genoa is collaborating with Rhode Island Hospital and CODAC Behavioral Healthcare on a study examining the effectiveness of pharmacist-delivered, medication-assisted treatment for opioid-use disorder.
 / PBN PHOTO/
RUPERT WHITELEY
OPIOID STUDY: Susan Lim, site manager, and Joe Robillard, pharmacy technician, work on prescription orders at a Genoa Healthcare pharmacy inside a Gateway Healthcare clinic in Pawtucket. Genoa is collaborating with Rhode Island Hospital and CODAC Behavioral Healthcare on a study examining the effectiveness of pharmacist-delivered, medication-assisted treatment for opioid-use disorder.
 / PBN PHOTO/
RUPERT WHITELEY
Efforts to curb the opioid epidemic include increasing access to care and reducing stigma, goals officials say a $1.6 million National Institutes of Health-funded, three-year study of pharmacy-administered, medication-assisted opioid addiction treatment promises to achieve. The study is a collaborative effort between Rhode Island Hospital, CODAC Behavioral Healthcare and Genoa Healthcare, seeking the effectiveness of…

Subscriber-only Content

This article is available only to PBN Subscribers. To get unlimited access, please subscribe by following the link below.

Subscribe Now

Already a subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -